Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 6/20 | 0.47 |
| ▸ | REN | P00797 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PEPD | P12955 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17335862 | 1.00 | L3MBTL1 (0.52) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL58729 | 0.95 | L3MBTL1 (0.48) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL12202698 | 0.95 | L3MBTL1 (0.48) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL5702217 | 0.89 | L3MBTL1 (0.42) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL5196736 | 0.89 | L3MBTL1 (0.42) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL5701987 | 0.89 | L3MBTL1 (0.42) | L3MBTL1ACERENLMNAHSD17B10 | |
| SCHEMBL1955287 | 0.84 | ACE (0.45) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL13101915 | 0.84 | ACE (0.45) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL27496955 | 0.82 | ACE (0.44) | ACERENLMNAHSD17B10KDM4E | |
| SCHEMBL4312891 | 0.81 | ACE (0.46) | ACERENLMNAHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3155436-B1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
| EP-3155436-A1 | ISOBARIC MASS LABELS | Electrophoretics Limited (GB) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015189413-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2015-12-17 | — | — | WO | disclosed |
| US-8629157-B2 | Pyrrolidine compounds which modulate the CB2 receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142677-A1 | Pyrrolidine Compounds Which Modulate The CB2 Receptor | CNR2, CNR1, OPRL1 | L3MBTL1 4514/4885ACE 3990/4885REN 3530/4885 |
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | L3MBTL1 102/4885ACE 1047/4885REN 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.